TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: The anti-CD30 monoclonal antibody SGN-30 conjugated with monomethyl auristatin E Brentuximab-Vedotin (BV) represents another interesting tool for the treatment of CD30+ PTCL.